Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm

NCT02296190 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Paroxysmal Supraventricular Tachycardia (PSVT)

Interventions

DRUG: Etripamil
DRUG: Placebo

Sponsor

Milestone Pharmaceuticals Inc.

Collaborators

[object Object]